Galaxy Surfact.

Galaxy Surfactants reported Q4 FY26 EBITDA of INR 122 crores, a decrease from INR 135 crores in Q4 FY25. The EBITDA per metric ton for Q4 FY26 was INR 20,114, down from INR 21,715 in Q4 FY25. This performance was influenced by effective pass-through of raw material prices and freight costs, an improved mix in the specialty segment, and disciplined cost control measures.

The West Asia war created a prolonged period of uncertainty, significantly impacting global supply chains, trade routes, and customer ordering behavior. This led to delays in inbound raw materials and outbound export shipments for the Egypt facility, causing port congestion and vessel availability issues. While logistics have gradually stabilized, transit times remain elongated, and the company is actively managing the situation through tighter planning.

India demonstrated resilience with an 8% year-on-year volume growth, driven by a 3% increase in the performance segment and over 27% growth in specialty volumes. In contrast, the AMET region faced significant challenges, with volumes declining 15% year-on-year in Q4. The Rest of the World (RoW) region saw a 7% year-on-year volume decline in Q4 but achieved 4% growth on a full-year basis. The Americas, however, emerged as a bright spot, showing strengthening demand momentum and reinitiated specialty pipelines post tariff reversals.

The Specialty segment reported a robust 27% annual growth, aligning with the company's Strategy 2030. Despite a seemingly flat quarter-on-quarter revenue (INR 493 crores in Q3 to INR 498 crores in Q4), this was attributed to a product mix impact post tariff reversals in the U.S. Management anticipates sequential improvement and projects a long-term specialty mix of 60-40% or 65-35% by 2031, emphasizing growth in both performance and specialty segments.

The geopolitical situation led to sharp and simultaneous escalation across input raw material prices, including both oleochemical and petrochemical feedstocks. Management confirmed its ability to pass on these increased costs to customers, albeit with a lag effect due to the need for price stability. The primary challenge currently is judiciously managing the supply side to ensure uninterrupted production amidst healthy demand.

Galaxy Surfactants invested approximately INR 480 crores in capex over the last three years, predominantly in the Specialty Ingredients segment. A significant portion of this capacity was commissioned in the last 1.5 years, and its monetization is expected to build momentum from the current financial year (FY27). The company believes it is well-equipped to capitalize on opportunities arising from supply-side challenges with its existing capacity.

Management acknowledged that progress in the newly introduced wellness segment has been slower than desired. While other strategic initiatives and product launches, such as Galsoft Lumithic, are on track, the wellness segment remains a 'work in progress.' This indicates an area where the company aims to improve its performance and accelerate development.